miR-181a |
Suppresses GRP78 expression |
Obesity (Mesitov et al., 2017)
|
miR-199a |
miR-30c |
Reduces ER stress |
Obesity (Menikdiwela et al., 2019)
|
miR-708 |
Induces ER stress |
Obesity (Menikdiwela et al., 2019)
|
miR-143 |
miR-34a |
Interacts with ER stress |
NAFLD (Gjorgjieva et al., 2019)
|
miR-122 |
Decreases UPR-mediated apoptosis |
NAFLD (Gjorgjieva et al., 2019)
|
miR-30 |
Downregulates of XBP-1 expression |
NAFLD (Gjorgjieva et al., 2019)
|
miR-26a |
Targets the eukaryotic initiation factor 2α and decrease ER stress and hepatic steatosis |
Hepatic steatosis (Xu et al., 2021)
|
miR-99b |
Induces ER stress |
Alzheimer's disease (Ye at al., 2015)
|
miR-100 |
miR-16-1 |
Inhibits Hsp70 and promotes α-synuclein aggregation |
Parkinson's disease (Zhang and Cheng, 2014)
|
miR-7 |
Reduces ER stress |
Parkinson's disease (Shen et al., 2021) |
miR-29a |
Induces ER stress |
Amyloid lateral sclerosis (Nolan et al., 2014) |
miR-103 |
Induces ER stress |
Atherosclerosis (Jiang et al., 2020)
|
miR-451-a |
Induces ER stress |
Colorectal cancer (Xu et al., 2019)
|
miR-663 |
Induces ER stress |
Hepatocellular carcinoma (Huang et al., 2016)
|